Anti-Inflammatory Medicine for Pets Market: How Are Monoclonal...

добавлена новая статья Health

2026-07-09 10:36:49 -

Anti-Inflammatory Medicine for Pets Market: How Are Monoclonal Antibodies Disrupting the NSAID-Dominated Canine and Feline Pain Market?

Monoclonal antibody anti-inflammatories in veterinary medicine — the biologic therapies (bedinvetmab/Librela for dogs, frunevetmab/Solensia for cats) targeting nerve growth factor (NGF) to block pain signaling without the renal, hepatic, and gastrointestinal toxicity of traditional NSAIDs representing the most significant therapeutic advance — create the most safety-transforming...

0 Комментарии 0 Поделились 30 Просмотры 0 предпросмотр